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Background: GADD45B is a member of the growth arrest DNA damage-inducible gene family associated with cell
growth control, apoptosis, and DNA damage repair response. The aim of this study is to detect the role of
GADD45B in colorectal carcinoma (CRC); the area not studied in depth to date.
Methods: The mRNA and protein levels of GADD45B were examined by Real-Time quantitative PCR (RT-qPCR) and
immunohistochemistry (IHC) in CRC tissues and adjacent noncancerous tissues (ANCT). Over-expression plasmids
and SiRNA were used to regulate GADD45B expression in CRC cell lines in vitro and flow cytometry and Western
blotting were used to detect apoptotic changes.
Results: The mRNA and protein levels of GADD45B were significantly higher in CRC tissues than those in ANCT
(P<0.05). Up-regulation of GADD45B was also correlated with relapse and death of CRC patients (P<0.05). The
Kaplan-Meier survival curves indicated that disease-free survival (DFS) was significantly worse in CRC patients who
showed GADD45B overexpression. A Cox multivariate analysis revealed that GADD45B overexpression and TNM
stage were significant factors affecting patients’ survival. On the other hand, as a tumor suppressor gene, GADD45B
amplified from normal colorectal tissues could induce apoptosis in CRC cell lines and may be associated with the
p53-mediated apoptotic pathways.
Conclusion: GADD45B, a tumor suppressor gene potentially through the p53-mediated apoptotic pathways, is
paradoxically overexpressed in CRC and as such may play an unappreciated role in tumorigenesis. The exact
mechanism of GADD45B inactivation and overexpression requires further investigation. GADD45B could be a
potential therapeutic target for CRC treatment in future.
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CRC is one of the most common malignancies world-
wide [1]. Many risk factors, such as inflammatory bowel
disease, inherited syndrome, diets low in fiber, smoke,
obesity, and heavy alcohol use, are related to intestinal
mucosa injury and dysplasia, and may result in carcino-
genesis of CRC [2,3]. However, the potential molecular
mechanisms of DNA damage from these exposures are
unknown. The development of CRC is a long and* Correspondence: dx2008cn@yahoo.com.cn
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reproduction in any medium, provided the orcomplicated process, including the activation of multiple
oncogenes and the inactivation of tumor suppressor
genes.
GADD45B is a member of the growth arrest DNA
damage-inducible gene (GADD45) family, which is com-
posed of GADD45A (GADD45), GADD45B (MYD118),
and GADD45G (cytokine response gene 6). This gene
family encodes small (18 kDa), evolutionarily conserved
proteins, sharing homology and high acidity [4].
GADD45B was previously identified as a primary re-
sponse gene in myeloid differentiation activated by
interleukin-6 in the mouse myeloid leukemia cell line
M1, which is associated with cell growth control, apop-
tosis, and cellular responses to DNA damage [5]. Recent
studies have reported that GADD45B may play antd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Wang et al. Journal of Translational Medicine 2012, 10:215 Page 2 of 10
http://www.translational-medicine.com/content/10/1/215important role in the carcinogenesis of human hepato-
cellular carcinoma and pituitary gonadotrope tumors
[6-8], but its role in CRC remains unclear. Therefore,
we examined both the mRNA and protein expression
of GADD45B, correlated the results with clinicopatho-
logic characteristics of CRC patients, and detected
GADD45B-induced apoptosis in CRC cell lines.
Methods
Patient samples
RNAlater-preserved solid tissues, formalin-fixed paraffin-
embedded (FFPE) archival CRC tissues and ANCT were
obtained from Fudan University Shanghai Cancer Center
between 2005 and 2008. The tumors were assessed
according to the WHO classification by two academic
gastrointestinal pathologists. The inclusion criteria were
as follows: colorectal adenocarcinoma (excluding mu-
cinous carcinoma); no preoperative chemotherapy or
radiotherapy; primary sporadic tumors. This study was
approved by the Ethical Committee of Fudan University
Shanghai Cancer Center for Clinical Research. The
written informed consents were obtained from all the
patients.
Cell culture and reagents
Dulbecco’s Modified Eagle’s Medium (DMEM), Roswell
Park Memorial Institute (RPMI) 1640 medium, penicillin,
streptomycin, Fetal Bovine Serum (FBS), trypsin-EDTA
(Ethylene Diamine Tetraacetic Acid) and Phosphate Buf-
fered Saline (PBS) were purchased from GIBCO BRL
(USA). Three human CRC cell lines, including LoVo,
SW620, and SW480 were purchased from American
Type Culture Collection (ATCC). LoVo (poorly differen-
tiated) and SW620 (highly metastatic) were cultured in
high glucose DMEM with 10% FBS, 100 units/ml peni-
cillin and 100 μg/ml streptomycin. SW480 (highly differ-
entiated) was cultured in RPMI 1640 supplemented with
10% FBS, 100 units/ml penicillin, and 100 μg/ml strepto-
mycin. All cells were cultured in a 5% CO2 incubator at
37°C. The primary antibodies GADD45B (H-70), P53
(DO-1), Bcl-2 (100), Bax (N-20), and caspase-3 p20 (N-19)
were purchased from Santa Cruz Biotechnology; β-actin
(13E5), cleaved PARP (Asp 214) and the secondary
antibodies (horseradish peroxidase–linked anti-mouse
immunoglobulin G, and anti-rabbit immunoglobulin G)
were purchased from Cell Signaling Technology.
RNA extraction and quantitative analysis of GADD45B
Total RNA was extracted from 64 pairs of CRC tissues,
ANCT, and cultured CRC cells using TRIzol reagent
(Invitrogen, Carlsbad, CA, USA) following the manufac-
turer’s instructions. The structural integrity of the total
RNA was confirmed by electrophoresis on 1% agarose
gels. The first strand of cDNA was reverse-transcribedfrom 500 ng total RNA in 20 μl using the cDNA Synthe-
sis Kit (Tiangen Biotech Co., Ltd., Beijing). GAPDH was
used as an endogenous control. The cycling conditions
for GAPDH and GADD45B were as follows: one cycle of
95°C for 5 minutes; 40 cycles of 95°C for 20 seconds,
58°C for 30 seconds, and 68°C for 45 seconds; and
one cycle of 72°C for 10 minutes. The specificity of amp-
lification was validated by a single peak in the melting
curves. The GADD45B gene was amplified with the fol-
lowing primes: 50-TGA CAA CGA CAT CAA CAT C-30
(the forward primer) and 50-GTG ACC AGA GAC AAT
GCA G-30 (the reverse primer). The endogenous GAPDH
gene was amplified with the following primers: 50-GAA
AGT CCG GAA GTC TCT GG-30 (the forward primer)
and 50-TAG AGA CTT GGG CAG TGT GG-30 (the
reverse primer). The standard curves for GAPDH were
generated using serial dilutions. Each RT-qPCR cycle
was repeated three times to confirm the results.
IHC analysis
152 FFPE blocks of CRC tissues and ANCT were col-
lected for tissue microarrays. Two CRC tissue cores
and two ANCT cores from the same patient’s FFPE
blocks were arranged on a recipient paraffin block (with
a 1 mm core per specimen). 5-μm thick paraffin sec-
tions were deparaffinized in xylene and rehydrated in a
graded alcohol series, boiled with 10 mmol/L of citrate
buffer (pH 6) for 15 min, treated with 0.3% H2O2 for
10 min, and preincubated in blocking solution (10%
normal goat sera) for 1 h at room temperature. The
steps were performed using the Envision two-step
method. The Envision and DAB Color Kit was pur-
chased from Gene Tech (Shanghai) Company Limited.
The GADD45B rabbit anti-human polyclonal antibody
was used at a 1:500 dilution. PBS was used as a nega-
tive control.
Tissue microarray slides were concurrently evaluated
by 2 of the authors. A granular cytoplasmic stain was
assessed as positive. Briefly, the staining index (SI, range
0–9) was considered as the product of the intensity score
(0, no staining; 1+, faint/equivocal; 2+, moderate; 3+,
strong) and the distribution score (0, no staining; 1+,
staining of <10% of cells; 2+, between 10% and 50% of
cells; and 3+, staining of >50% of cells). For GADD45B
protein in this study, a moderate/strong cytoplasm stain-
ing of (SI = 3–9) was defined as positive staining, while a
weak or negative staining (SI = 0–2) was defined as nega-
tive staining [9,10].
Construction of pEGFP-N1-GADD45B
cDNA from normal colorectal tissues was amplified by
PCR. The PCR product and the pEGFP-N1 plasmid vec-
tor were double digested with BglII/SalI enzymes and
then ligated using T4 DNA ligase. The ligated product
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cells, coated to the LB solid medium containing kanamy-
cin (100 ug/ml), and stored at 37°C overnight. A selec-
tion of white colonies was amplified using the PCR
reaction, and the positive clone was incubated in a LB li-
quid medium (kanamycin 100 ug/ml) with agitation
overnight. The recombinant plasmid was extracted the
next day. Identification of the correct plasmid was sent
to Shanghai R&S Biotechnology for sequencing. The re-
sult of DNA sequencing was consistent with the
PubMed database. The plasmid sequence was named
pEGFP-N1-GADD45B. SW480 (3*105 cells/dish) were
transplanted into 35 mm dishes 1 day before transfec-
tion. After 70% confluence was reached, 2 μg of plasmid
DNA was diluted with 100 μl serum-free medium (with-
out antibiotics). The transfection complex was then
formed by adding the FuGENEW HD Transfection Re-
agent (Roche Diagnostics, Mannheim, Germany) to the
tube containing the diluted DNA. The transfection com-
plex was mixed and incubated for 15 minutes at room
temperature. The mixture was then added to each dish
(there is no need to remove the old medium and replace
it with fresh medium) and stored in a 5% CO2 incubator
at 37°C.SiRNA synthesis
Small interfering RNA (SiRNA) duplexes were synthe-
sized and tested for the specific inhibition of GADD45B
expression. SW620 (3*105 cells/dish) were transplanted
into 35 mm dishes 1 day before transfection. After 70%
confluence was achieved, 100 pmol Si-GADD45B (pur-
chased from Shanghai GenePharma Co., Ltd.) was
diluted with 100 μl serum-free medium using the
FuGENEW HD Transfection Reagent, according to the
manufacturer’s instructions.Cell apoptosis analysis
The induction of apoptosis by Si-GADD45B and
pEGFP-N1-GADD45B in SW620 and SW480 was deter-
mined by flow cytometry using the Annexin V-FITC
Apoptosis Detection Kit. Briefly, 3*105 cells were plated
and treated with Si-GADD45B and pEGFP-N1-
GADD45B for 24 hours. The cells were then harvested,
washed in PBS, and incubated with Annexin V and pro-
pidium iodide in a binding buffer in the dark at roomTable 1 GADD45B expression in CRC tissues and ANCT
n GADD45B mRNA P n
CRC 64 23625.6±4028.1a <0.05 152
ANCT 64 21318.2±4549.9 152
a gene copy numbers using SYBR Green.temperature for 10 minutes. The stained cells were ana-
lyzed using the Beckman Coulter Flow Cytometer.
Western blotting analysis
Whole cell lysates were generated using the cell lysis
solution, followed by centrifugation and the collection
of the supernatant fraction for immunoblotting. Pro-
teins were separated using SDS-PAGE gel electrophor-
esis and transferred onto a nitrocellulose membrane.
After blocking with 5% non-fat milk in blocking buffer
(20 mmol/l of PBS containing 0.1% Tween 20), the
membrane was incubated with the primary antibody
at 4°C overnight and incubated with the appropriate
horseradish peroxidase-conjugated secondary antibo-
dies the next day for 1 hour at room temperature.
The immunoreactive bands were visualized using the
ECL Plus Western Blotting Detection System. The
level of β-actin for each sample was used as a loading
control.
Statistical analysis
The experimental data were expressed as the mean ±
standard deviation, and the statistical significance be-
tween different groups was determined using t-tests.
The relationship between GADD45B expression and
clinicopathological features of CRC patients was ana-
lyzed using χ2 and Fisher’s exact tests. Statistical signifi-
cance was defined as a P-value less than 0.05.
Results
Quantitative analysis of GADD45B mRNA expression
GADD45B and GAPDH mRNA expression was calcu-
lated using the absolute quantification method according
to the parameter threshold cycle (Ct) and gene copy
numbers [11]. Melting curves of GADD45B and
GAPDH with single peaks indicated good specificity.
The standard curve formulas, Y=35.9–4.555X (r2=0.999),
for GAPDH was derived from the lines of the calibration
curves. The average amount of GADD45B mRNA in
CRC tissues was significantly higher than that in ANCT
(P <0.05, Table 1).
IHC analysis of GADD45B protein expression
In the IHC analysis, positive staining of GADD45B pro-
tein was noted in 109 of the 152 (69.1%) paraffin-
embedded CRC tissues, while negative staining wasGADD45B protein χ2 P
Positive Negative
105 (69.1%) 47 (30.9%) 45.805 0.000
46 (30.3%) 106 (69.7%)
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(Table 1, Figure 1). Table 2 summarizes the correlation
of GADD45B expression with the clinicopathological
features of CRC patients. The age of patients ranged
from 29 to 75 years with a median age of 63 years;Figure 1 Illustrates IHC of GADD45B in tissue microarrays (EnVision×4
tissues showing little or very weak staining of epithelia. (C) ANCT showing
and DFS/OS. 0: GADD45B not overexpressed; 1: GADD45B overexpressed.54.6% were men (83 of 152), and 45.4% were women (69
of 152). GADD45B expression was not correlated with
patients’ sex, age, tumor size, location, gross type, dif-
ferentiation and TNM stage. The up-regulation of
GADD45B was correlated with the relapse and status00). (A) CRC tissues showing strong cytoplasmic staining. (B) CRC
negative staining. (D-E) Relationship between GADD45B expression
Table 2 Relationship between GADD45B expression and
clinicopathological features in CRC patients
Clinicopathological features n GADD45B n (%) χ2 P
Gender 0.116 0.734
Male 83 59 (71.1%)
Female 69 46 (66.7%)
Age (years) 0.400 0.527
<60 93 66 (71.0%)
>=60 59 39 (66.1%)
Tumor size (cm) 0.079 0.779
<5 88 60 (68.2%)
>=5 64 45 (70.3%)
Location 3.143 0.076
Colon 101 65 (64.4%)
Rectum 51 40 (78.4%)
Gross type 0.055 0.973
Massive 57 42 (70.0%)
Ulcerative 81 57 (68.7%)
Invasive 8 6 (66.7%)
Differentiation 2.280 0.320
Well 5 3 (60%)
Moderate 113 75 (66.4%)
Poor 34 27 (79.4%)
TNM stage 2.114 0.146
II 87 56 (64.4%)
III 65 49 (75.4%)
Relapse 5.390 0.020
Yes 47 37 (78.7%)
No 90 53 (58.9%)
Status 4.269 0.039
Survival 102 62 (60.8%)
Death 35 28 (80.0%)
Table 3 Univariate regression model of prognostic
covariates in CRC patients
Characteristics DFS OS
χ2 P χ2 P
Sex 0.835 0.361 0.973 0.324
Age 0.104 0.747 1.716 0.190
Location 0.160 0.689 0.017 0.897
Size 0.020 0.888 0.207 0.649
Gross type 0.832 0.660 0.322 0.851
Differentiation 3.939 0.140 1.972 0.373
TNM 6.155 0.013 1.793 0.181
GADD45B expression 4.915 0.027 2.586 0.108
Abbreviations: DFS disease free survival, OS overall survival.
The results represent poorer DFS in stage III patients and GADD45B-
overexpressed patients.
Figure 2 Displays GADD45B expression in CRC cell lines and
transfection efficiency. (A) GADD45B expression was different in
three CRC cell lines: highest in SW620, lowest in SW480, and
moderate in LoVo. (B-C) Fluorescent (GFP) image and bright field
image (the same area) of SW620 at 24 h after transfection under
converted fluorescent microscopy.
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Patients with higher GADD45B expression tended to
have a higher risk of relapse and death.
All patients were followed up for at least 4 years. After
4 years, 102 patients were still alive, 35 patients suc-
cumbed to the disease, and 15 patients declined to con-
tinue the participation in the study. The median survival
time of CRC patients was 48 months. DFS was signifi-
cantly worse in CRC patients with GADD45B overex-
pression than in patients that did not overexpress
GADD45B (P= 0.027, Figure 1D, 1E, Table 3). As shown
in Table 3, stage Ш patients were also significantly asso-
ciated with a poorer DFS (P = 0.013) compared with
stage II patients. To assess whether GADD45B and
TNM stage could be used as independent prognostic
factors or not, a Cox model was generated using univari-
ate analysis. The results indicated that combined analysisof GADD45B and TNM stage was of statistically signifi-
cance (χ2=9.979, P=0.007).
Detection of GADD45B background expression in
CRC cell lines
RT-qPCR was used to qualify GADD45B expression in
different CRC cell lines, including LoVo, SW480, and
SW620. As shown in Figure 2A, mRNA expression of
GADD45B was the highest in SW620, the lowest in
SW480, and moderate in LoVo. Therefore, in the follo-
wing work, we chose SW480 for overexpression experi-
ments and SW620 for inference experiments.
Successful construction of pEGFP-N1-GADD45B and
synthesis of Si-GADD45B
To determine whether the construction of pEGFP-N1-
GADD45B was successful, the recombinant plasmid was
verified using PCR and electrophoresis. In the 483 bp lo-
cation, there were evident bands of the PCR products.
Meanwhile, the pEGFP-N1-GADD45B plasmid structure
was also confirmed by double-enzyme cleavage (BgII/SaI
enzyme) and gene sequence analysis. Two aim bands, at
4.7 kb and 483 bp, were acquired. After the successful
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ical synthesis of the Si-GADD45B duplexes, plasmid
DNA and Si-RNA were transfected into CRC cell lines.
The transfection efficiency was between 70% and 80%,
as assessed with converted fluorescent microscopy
(Figure 2B, 2C).
Apoptosis analysis in human CRC cells
To determine whether the overexpression or inhibition
of GADD45B in CRC cells was associated with the in-
duction of apoptosis, SW480 and SW620 cells were trea-
ted with pEGFP-N1-GADD45B and Si-GADD45B as
described above. The numbers of apoptotic cells were
assessed using the Annexin V-FITC Apoptosis Detection
kit. Transfection with Si-GADD45B in SW620 for
24 hours resulted in a significant decrease of apoptotic
cells (Figure 3A, 3B); while transfection with pEGFP-N1-
GADD45B in SW480 for 24 hours resulted in a signifi-
cant increase of apoptotic cells (Figure 3C, 3D). This
indicated that pEGFP-N1-GADD45B could effectively
induce apoptosis in CRC cell line, while Si-GADD45B
had the opposite effect (P<0.05, Figure 3E, 3F).
Expression of apoptosis-related proteins by Western
blotting
Transfection of CRC cells with pEGFP-N1-GADD45B
resulted in an increase in GADD45B, while transfection
with Si-GADD45B showed a decrease in GADD45B
(Figure 4A). Early studies showed that p53 can bind theFigure 3 Shows induction of apoptosis in human CRC cell lines. (A) Ap
Apoptosis assay in SW620 transfected with Si-GADD45B. (C) Apoptosis assa
SW480 transfected with pEGFP-N1-GADD45B. (E-F) Apoptotic changes in SBax gene promoter region and regulate Bax gene tran-
scription [12,13]. The Bcl-2 protein family plays a critical
role in the regulation of apoptosis [14]. Because we
observed apoptotic changes in CRC cells, we analyzed
the levels of P53, Bax and Bcl-2 in cells treated with
pEGFP-N1-GADD45B and Si-GADD45B, respectively.
SW480 transfected with pEGFP-N1-GADD45B showed
an increase in the level of P53 and Bax protein, with a
concomitant decrease in the level of Bcl-2, when com-
pared with the control cells. SW620 transfected with
Si-GADD45B showed a decrease in the level of P53 and
Bax protein, with a concomitant increase in the level of
Bcl-2 (Figure 4A).
Caspase-3, as a critical executioner of apoptosis,
cleaves a broad spectrum of cellular target proteins, in-
cluding nuclear PARP that leads to a cell death cascade
[15]. To clarify how the apoptotic pathway was activated
by GADD45B, we examined the effects of pEGFP-N1-
GADD45B on the activation of Caspase-3 and PARP.
Transfection with pEGFP-N1-GADD45B in SW480
resulted in an obvious increase in the cleavage of PARP
and a decrease in unactivated caspase-3 (Figure 4A).
This indicates that the canonical mitochondrial apop-
totic pathway may be activated by pEGFP-N1-
GADD45B.
In addition, expression of these apoptosis-related pro-
teins was also detected in CRC tissues. In paired CRC
tissues and ANCT, apoptosis-related proteins expressed
differently (Figure 4B). P53 and Caspase-3 has theoptosis assay in SW620 transfected with vectors as control. (B)
y in SW480 transfected with vectors as control. (D) Apoptosis assay in
W620 and SW480 after transfection. * indicates P<0.05.
Figure 4 Confirms expression of GADD45B and apoptosis-related proteins by Western blotting. (A) Expression of GADD45B and
apoptosis-related proteins in CRC cell lines after transfection with pEGFP-N1-GADD45B and Si-GADD45B. (B) Expression of GADD45B and
apoptosis-related proteins in CRC tissues and ANCT.
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implications for prognosis.
Discussion
CRC carcinogenesis is a complicated and multifactorial
process resulting from many environmental exposures.
This process involves the combined actions of multiple
oncogenes and tumor suppressor genes [16]. As a nega-
tive growth-control gene, GADD45B is implicated in
DNA damage, cell cycle arrest, and apoptosis. According
to reports in the literature, higher expressions of
GADD45B are associated with a higher risk of re-
currence based on a cluster analysis of patients with
stage II/III colon cancer treated with surgery alone or
surgery plus adjuvant fluorouracil plus leucovorin [17].
Our study was consistent with the above research. To
investigate the role of GADD45B in CRC, we first
detected GADD45B expression in 64 pairs of CRC and
ANCT by RT-qPCR. The results indicated that
GADD45B was significantly up-regulated in CRC. Tissue
microarrays are reliable tools for the clinicopathological
characterization of cancer tissues [18,19]. The IHC ana-
lysis in 152 CRC patients using tissue microarrays further
confirmed the results of the RT-qPCR and also observed
that up-regulation of GADD45B expression was corre-
lated with relapse and death in CRC patients (P<0.05).
The patients with higher GADD45B expression tended
to have a higher risk of relapse and death. The Kaplan-
Meier survival curves indicated that DFS was significantly
worse in CRC patients that overexpressed GADD45B. ACox multivariate analysis revealed GADD45B expression
and TNM stage as significant factors affecting survival.
GADD45B overexpression in patients and stage III
patients were significantly associated with a poorer DFS
(P<0.05). Therefore, we postulated that abnormal expres-
sion of GADD45B might be involved with the carcino-
genesis of CRC and it showed potential for use as a
prognostic marker in future.
Until now, the GADD45 gene family, including
GADD45A, GADD45B and GADD45G, has been recog-
nized as stress sensors that modulate the response of
mammalian cells to genotoxic and physiological stresses
and the process of tumor formation and progression
[4,20-22]. GADD45B shares the common functions of
the GADD45 family, including the regulation of cell
growth, cell apoptosis, cellular responses to DNA dam-
age and anti-tumor immune responses [23-25]. The
overexpression of GADD45B has been shown to inhibit
cell growth in a variety of human tumor cell lines, in-
cluding hepatocellular carcinoma cells, prostate cancer
cells, breast cancer cells and others [26-28]. To investi-
gate the function of GADD45B in CRC, we constructed
a pEGFP-N1-GADD45B vector, synthesized SiRNA
duplexes, and then respectively transfected them into
three CRC cell lines. After successful transfection with
high efficiency, we performed an analysis of cell apop-
tosis using the flow cytometric method. Compared with
the control group, the cells transfected with pEGFP-N1-
GADD45B had more apoptotic cells, whereas the cells
transfected with Si-GADD45B had fewer apoptotic cells.
Wang et al. Journal of Translational Medicine 2012, 10:215 Page 8 of 10
http://www.translational-medicine.com/content/10/1/215We also investigated the effects of pEGFP-N1-GADD45B
and Si-GADD45B on the expression of apoptosis-related
proteins in CRC cells by Western blotting and found
that the mitochondrial apoptotic pathway was activated
by GADD45B. Therefore, as a tumor suppressor gene,
GADD45B could induce apoptosis in CRC cell lines.
According to the results of RT-qPCR and IHC, we
presumed that GADD45B might lose its normal func-
tions and promote carcinogenesis in CRC tissues. This
inconsistency of GADD45B functions between in vitro
cellular-level and in vivo tissue-level may be due to
complex micro-environment in human body and the
resulting abnormal gene expression. The potential mech-
anism needs for further exploration.
Because the colon and rectum are important digestive
organs, the intestinal mucosa can be easily damaged by
various factors [29-31]. The human CRC-prone disor-
ders may contribute to the risk of CRC through the ac-
cumulation of specific products resulting from DNA
damage. In our study, we found that CRC had a high ex-
pression of GADD45B, which is involved in the regula-
tion of cell growth and apoptosis. This result suggested
that CRC cells might accumulate a certain amount of
DNA damage, leading to dysfunction and over-
expression of GADD45B. In this scenario, under
chronic genotoxic stress, the failure to appropriately
repair DNA damage and control growth may contrib-
ute to colorectal carcinogenesis.
In human solid tumors, DNA damage and repair
defects that lead to tumorigenesis usually involve mul-
tiple factors. Defects in functional p53, p21 (Cdkn1a), or
growth suppression genes, such as those of the GADD45
gene family, could be involved [32]. p53 is the most
commonly mutated gene in cancer, exerting its activity
by binding DNA response elements and regulating the
transcription of specific genes in response to various
stimuli, thus directing cells toward cell cycle arrest or
apoptosis [33]. Because p53 functions mainly as a tran-
scription factor, it is important to explore the genes
regulated by p53 that contribute to the regulation of
apoptosis. In this study, we investigated how the changes
of GADD45B expression influence apoptosis-related
proteins expression. Our results showed that transfec-
tion with pEGFP-N1-GADD45B in SW480 led to an in-
crease in P53, Bax and cleavage of PARP, as well as a
decrease in Bcl-2 and unactivated caspase-3. We postu-
lated that GADD45B-induced apoptosis may be asso-
ciated with the p53-Bax mitochondrial apoptotic
pathway. As apoptotic pathways are frequently altered in
tumor progression, proteins associated with this pathway
may have potential as prognostic biomarkers. Like other
researches, we have shown pro-survival function of
Bcl-2, pro-apoptotic function of Bax, and elevated ex-
pression of P53 and caspase 3 in CRC tissues and ANCT[34-36]. Determination of the tumors ability to undergo
apoptosis holds immense potential as a new prognostic
marker for CRC.
Cancer can be viewed as the result of a succession of
genetic changes during which a normal cell is trans-
formed into a malignant one. Apoptosis is intimately
connected with the elimination of potentially malignant
cells, hyperplasia and tumor progression [37]. The abun-
dance of literature suggests that defects along apop-
totic pathways play a crucial role in carcinogenesis.
GADD45B, as a tumor suppressor potentially through
the p53-mediated apoptotic pathways, is paradoxically
overexpressed in CRC and as such may play an un-
appreciated role in tumorigenesis. Defects in this gene
might have broken some kind of balance of pro-
apoptotic and anti-apoptotic proteins contributing to
evasion of apoptosis and carcinogenesis.
Several studies have reported that GADD45B was
decreased in human hepatocellular carcinoma (HCC)
[8,38]. Compared with the high levels of staining in
colon cancer, breast cancer, prostate cancer, lymphoma,
squamous cell carcinoma, and leiomyosarcoma, the
under-expression of GADD45B was specific to liver can-
cer. As a novel pituitary tumor suppressor, microarray
data showed the loss of GADD45B in gonadotrope
tumors where its repression modulates cell proliferation,
survival, and tumorigenicity [6]. The hierarchical cluster-
ing of 19 pancreatic neuroendocrine tumors (PNETs)
revealed that GADD45B was one of the most highly up-
regulated genes in the malignant group of PNETs [39].
Therefore, there is still controversy regarding the ex-
pression and function of GADD45B in various tumors.
Abnormal expression of GADD45B is similar to tumor
suppressor p53 and phosphatase and tensin homologue
(PTEN), both of which showing high expression in
some head and neck cancers, and mammary cancer
[40-42]. Further investigations are needed to determine
the underlying mechanisms behind the dysfunction of
GADD45B and CRC tumorigenesis.
Conclusion
In this study, GADD45B was significantly overexpressed
in CRC compared with ANCT. Our results suggest that
increased expression of GADD45B may play an import-
ant role in CRC carcinogenesis and be used as a useful
prognostic marker in future. Expression of GADD45B in
CRC was abnormal; this gene may lose its normal func-
tions as a tumor suppressor gene. We postulate that
GADD45B may have undergone mutation, promotor
hyper-methylation of the CpG islands or other molecular
biology changes which need further investigation.
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